A baby skincare OEM programme in China fails in a specific, avoidable way. The brief goes out, the sample comes back in seven days, the buyer approves it, the deposit is wired, and three weeks later the plant's quality manager mentions that infant products need a different scope annotation on the production licence than the one the plant is currently operating under for your product form — and the run cannot be released until that is sorted out. The formula was fine. The pack was fine. The paperwork that authorises the plant to make that category of product for that age group was the thing nobody checked, and it is the one item on the list you cannot fix from the buyer's side.
This article explains what a Chinese cosmetics production licence scope is, why infant and child products sit under a stricter one, how to read the document a supplier sends you, and what to demand in writing before you set a launch date. The licence scope question matters for any category, but for baby skincare OEM China licence scope is the gating item — everything else in the programme depends on it.
Why a production licence has a "scope" at all
Every cosmetics manufacturer in mainland China operates under a cosmetics production licence issued by the provincial medical products administration — in Guangdong, the Guangdong Medical Products Administration. The licence is not a single yes-or-no credential. It carries a list of permitted production items, organised by dosage-form unit: broadly, general liquid products, cream and emulsion products, powders, aerosol and organic-solvent products, wax-based products, and a residual "other" unit. A plant licensed for creams and emulsions is not thereby licensed for aerosols; it would need the aerosol unit added, with the corresponding facility inspection.
Layered on top of the dosage-form units is a set of category conditions that are stricter than general cosmetics. Two matter for a buyer sourcing baby products:
- Children's cosmetics. Since the children's-cosmetics rules introduced by the national regulator in the early 2020s, products intended for children under a defined age carry their own labelling mark, their own formulation principles (a stated preference for fewer ingredients and restrictions on certain ingredient classes), and — critically for the OEM buyer — a requirement that the manufacturing plant meet the stricter production quality management conditions applicable to children's skincare, which is recorded against the plant's licence. A plant that has not had that recorded is not authorised to make the product, however good its cream line is.
- Eye-area products, which share the stricter production-condition tier. If your baby range includes anything for use around the eyes, it lands here too.
The facts published for Yadun Cosmetics say exactly this in the plant's own listing: infant and child skincare sits under a dedicated licence scope rather than general cosmetics, and buyers should ask the factory for the specific scope covering their product before committing to a launch date. That is the correct framing, and it applies to every Guangzhou plant offering baby care, not just this one.
An insider detail: the annotation is per plant and per site, not per company. A manufacturer with two production addresses may hold the children's-product condition at one and not the other. If the supplier's quoting entity and production address differ, the scope you need is the one on the licence for the address where your product will physically be compounded and filled.
What the document looks like, and what to check on it
When you ask for the licence, you should receive an image or scan of the original certificate, not a typed summary. Read it against this table.
| Field on the licence | What to check | Red flag |
|---|---|---|
| Licence holder name (in Chinese) | Matches the business licence entity and the entity on your pro-forma | Different entity — you may be dealing with a trading company or a sister plant |
| Production address | Matches the address where your product will be made | Address differs from where the sample was made or where you audited |
| Permitted production items (dosage-form units) | Includes the unit for your product form — creams/emulsions for a baby lotion, general liquids for a wash | Your form is missing; a promise to add it later is a timeline risk |
| Category conditions / annotations | Explicitly records children's skincare (and eye-area, if relevant) | No annotation — ask directly; do not assume |
| Issuing authority | Provincial medical products administration | Any other issuer |
| Validity dates | Current, with enough runway to cover your production and reorders | Expiring within your programme window; renewal timing is a plant problem that becomes your problem |
| Licence number | Present and legible | Withheld or blurred |
Two verification habits that separate careful buyers from hopeful ones:
- Check the licence number against the regulator's public query service. Chinese provincial regulators publish searchable databases of cosmetics production licences. Have someone who reads Chinese confirm the number, entity, address, permitted items and validity match what you were sent. This takes minutes and catches stale or edited scans.
- Match the licence to the business registration. The unified social credit code on the business licence and the entity name on the production licence should agree. For Yadun Cosmetics, the listing publishes the registered entity 广州市白云区雅顿化妆品厂 with USCC 914401016893182532 and a Renhe Town, Baiyun District address, established 2009; the listing also states that the plant holds a cosmetics production licence issued by the Guangdong Medical Products Administration, with the licence number and validity to be published only once the original has been inspected. That last sentence is the standard you should apply to every supplier: numbers and dates only after the original has been sighted, by you or by someone acting for you. The general method is in the China supplier verification guide.
Note what the listing does not say, and what this article therefore does not say either: whether the scope wording covers infant products specifically. That is unpublished. Ask for it.
Beyond the paper: three production questions the scope does not answer
A licence annotation tells you the plant has been inspected against the stricter tier. It does not tell you how the plant runs your product day to day. Three things to ask, none of which is published for this or most plants:
Segregated or shared lines
Infant skincare formulations tend to be low-fragrance or fragrance-free and use a narrower preservative palette than adult products. The practical risk on a shared filling line is carry-over: a fragranced adult lotion filled before your unscented baby lotion leaves residue in the hopper, the filling heads and the nozzles unless the cleaning validation is designed for that changeover. Ask whether infant products run on dedicated equipment, or on shared lines with a validated cleaning procedure between products, and ask to see the cleaning record format. A plant that can show you a line-clearance form with a signed-off residue check is answering the question properly; one that says "of course we clean" is not.
Fragrance and preservative policy
The children's-cosmetics formulation principles in China push toward fewer ingredients and away from certain classes. Destination markets have their own expectations — the EU safety assessment for products intended for children under three is more demanding than for adult products, and UK practice follows a similar logic. Ask the plant for its written policy on which fragrance materials and preservatives it will and will not use in infant formulations, and whether it will formulate to your destination market's restricted-substance list on request. Then have your own safety assessor review the formula; the plant's policy is an input to your assessment, not a substitute for it. Do not accept, and do not make, any claim that a formulation is "safe for babies" or "dermatologist tested" without your own substantiation — that is a brand-owner obligation in every market.
Raw-material traceability
Children's products in China require tighter raw-material controls, including supplier qualification and incoming inspection records for each ingredient lot. Ask how the plant traces an ingredient lot to a finished-goods batch, and request a sample batch record from a previous run (with the customer's identity redacted). If the plant cannot produce one, it either does not keep them in that form or will not share them; either way, you have learned something before the deposit.
Timeline: where the scope check sits relative to sampling and production
The trap in the opening paragraph happens because sampling is fast and licensing is slow. This plant publishes standard-formulation samples in about three days and custom development in about seven, with production in 15–30 days after sample approval. A sample can be on your desk before your Chinese-reading colleague has finished checking the licence database. Sequence the programme so the paperwork gate closes before the sample gate opens:
- Week 0 — Request documents. Business licence, production licence with all pages and annotations, and a written statement naming the scope item under which your specific product (form + age group) will be manufactured. Use the documents-before-first-order checklist as the base list and add the scope statement to it.
- Week 0–1 — Verify. Regulator database lookup; entity and address match; validity check against your programme window. If the annotation is missing, stop here and ask the plant for its plan and timeline to obtain it — then decide whether to wait or look elsewhere. Do not brief a formula against a scope that does not yet exist.
- Week 1 — Brief and sample. Only now send the development brief. Include the destination market, the age range, the free-from list, the pack, and a benchmark sample.
- Week 2–3 — Sample review and safety assessment kick-off. Your assessor needs the full formula with percentages and the raw-material documentation; request these with the sample, not after approval.
- Week 3+ — Pilot order. Written MOQ basis, batch record commitment, and a clause in the purchase order stating that the product will be manufactured at the licensed address under the named scope item, with a copy of the licence annexed.
The purchase-order clause is the practical protection. If the plant later discovers a scope problem, the clause makes it their contractual issue rather than a shrug.
The scope checklist
Send this as a single document request and do not release a deposit until each item is answered.
- [ ] Scan of the full cosmetics production licence, all pages, including any annotation pages
- [ ] Written statement of the exact permitted production item and category condition covering your product (e.g. cream/emulsion unit + children's skincare condition)
- [ ] Confirmation that the production address on the licence is where your product will be compounded and filled
- [ ] Regulator database lookup screenshot or your own check, matching number, entity, address, items and validity
- [ ] Business licence with unified social credit code, matched to the production licence entity
- [ ] Statement on segregated versus shared lines for infant products, plus a sample line-clearance record
- [ ] Written fragrance and preservative policy for infant formulations
- [ ] Sample batch record from a prior run, customer identity redacted
- [ ] Any public administrative-penalty record for the entity in the last three years, and the plant's account of it — provincial regulators publish enforcement decisions, and a buyer of children's products should read them rather than rely on assurances of a clean record
- [ ] Purchase-order clause naming the licence, address and scope item
That penultimate item deserves a sentence. Public enforcement records exist for many plants in the Guangzhou cluster, across every size and category. Their presence is not automatically disqualifying; what matters is what the finding was, whether it touched the product category you are buying, and what corrective action the plant can document. Ask, read, decide. Any supplier that describes its own compliance history in absolute terms is telling you it has not read its own record.
Common questions
Is a general cosmetics production licence enough for a baby lotion?
No. The dosage-form unit covers the lotion as a physical product form; the children's-product condition is what covers the intended user. You need both to appear on the licence for the production address in question. A plant that holds the first without the second can make adult lotion, not infant lotion.
Does the Chinese licence scope have any bearing on my US or EU market entry?
Not directly. Your destination market's requirements — product safety assessment, responsible person, labelling, ingredient restrictions — are the brand owner's obligation, and a Chinese production licence is not a substitute for any of them. What the scope does is tell you whether the product can legally be manufactured at all, and it signals that the plant has been inspected to the stricter production tier. Treat it as a manufacturing prerequisite, not as a market clearance.
Can the plant add the children's condition to its licence if it does not have it?
Plants can apply for scope changes, which involve a facility inspection by the provincial regulator. The timeline is out of your control and can run months. If a supplier proposes adding the scope for your project, price the delay honestly and ask for evidence that the application has actually been lodged.
What if the supplier says the licence is confidential?
Production licence details are public record in China; the regulator publishes them. A supplier withholding a document that any Chinese-reading buyer can look up is either not the manufacturer or not confident in what the document says. Either way, treat the refusal as an answer.
What to ask the supplier next
- Which exact permitted item and category condition on your production licence covers my product form and age group?
- Is the production address on the licence the address where my product will be made?
- Do infant products run on dedicated lines, and can you show a line-clearance record?
- What is your written fragrance and preservative policy for children's formulations, and will you formulate to my destination market's list?
- Can you supply a redacted batch record from a previous infant-product run?
- Will you accept a purchase-order clause naming the licence and scope item?
Yadun Cosmetics is a reasonable case to test these questions on: a Guangzhou contract manufacturer whose listing names baby care as one of eight product lines, states plainly that the category sits under a dedicated licence scope, tells buyers to ask for that scope in writing, and reports a production licence from the Guangdong regulator whose number and validity are being withheld until the original has been inspected. That is the right posture for a listing to take, and the right posture for you to take with every supplier — read the factory profile alongside the licence scan you ask them to send, and do not set the launch date until the two agree.
